Resonance Specialties Ltd. (BSE: 524218) is a Mumbai, Maharashtra-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹327 Cr, it ranks #2,279 by market cap among the 6,197 Indian listed companies on FinBizNet, and #9 of 13 in Custom Synthesis and Specialty CDMO. At ₹275.70 (as of 16 Nov 2026), the share price is 14.7% below its 52-week high of ₹323.20 and 253.8% above its 52-week low of ₹77.93. The share price is up 203.4% over one year and up 57.9% over three months.
| Current Price | ₹275.70 |
|---|---|
| Market Cap | ₹327 Cr |
| BSE Code | 524218 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | 31.5 |
| Return on Equity | 15.15% |
| Return on Assets | 9.46% |
| 52-Week Range | ₹77.93 – ₹323.20 |
| 1-Year Price Change | +203.4% |
| 3-Month Price Change | +57.9% |
| Beta (1Y) | 0.23 |
| Dividend Yield | 0.35% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.resonancesl.com |
Delivery averaged 68.9% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate, chromium polynicotinate, niacin, pyrazinamide and isoniazid; alpha picolinic and dipicolinic acids; solvents comprising acetonitrile and valeronitrile; and lutidines and collidines for anti-ulcer drugs. The company was formerly known as Armour Polymers Limited. Resonance Specialties Limited was incorporated in 1989 and is based in Mumbai, India.
1. Chemical Manufacturing-This segment manufactures pyridine, picoline, cynopyridine, and related derivatives. 2. Manufacturing-This segment manufactures pyridines, picolines, lutidines, collidines, and cyanopyridines. 3. Services-0
1. Chemical Manufacturing-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,570 Cr | 79.6 | 5.76% | ₹806 Cr | +20.1% |
| Neogen Chemicals Limited (Neogen) | ₹8,322 Cr | 259.2 | 3.58% | ₹296 Cr | +93.4% |
| Prasol Chemicals Limited | ₹4,681 Cr | 58.1 | — | ₹413 Cr | — |
| Laxmi Organic Industries Ltd | ₹4,574 Cr | 57.2 | 4.08% | ₹1,083 Cr | -18.9% |
| Tatva Chintan Pharma Chem Ltd | ₹3,871 Cr | 92.5 | 5.53% | ₹217 Cr | +12.2% |
| Paushak Ltd. | ₹1,487 Cr | 38.1 | 8.22% | ₹89 Cr | — |
| Sunshield Chemicals Ltd. | ₹833 Cr | 25.2 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹733 Cr | 31.8 | 4.80% | ₹65 Cr | -12.8% |
| Resonance Specialties Ltd. | ₹327 Cr | 31.5 | 15.15% | — | +203.4% |
Listed by market capitalisation. Ratios are shown for context only.
Resonance Specialties Ltd. is trading at ₹275.70, with a market capitalisation of ₹327 Cr.
Resonance Specialties Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Resonance Specialties Ltd. has a P/E of 31.5 and a return on equity of 15.15%.
Resonance Specialties Ltd. is listed on the BSE under the scrip code 524218.
Resonance Specialties Ltd.'s share price is up 203.4% over one year and up 57.9% over three months. Its 52-week range is ₹77.93 to ₹323.20.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.